Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2025 and 2026.
Financials
Financial year 2026
APOTHEEK JANSSEN from Knokke-Heist, company number BE0426331232, closed financial year 2026 with a result of € -1,792 after tax. For that financial year APOTHEEK JANSSEN recorded a gross margin of € 43,763 and equity of € 189,458. Compared with financial year 2025, the result moved from € -26,239 to € -1,792. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 1, 2026.
€ 189,458
▼ 1% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -1,792
▲ 93 % less loss than in 2025
Profit after tax over the fiscal year.
€ 11,822
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 127,458.
People and assets in 2026
0.3
▼ 0.3 vs 2025
Average over the fiscal year, from the social balance sheet.
€ 11,228
▼ 29% vs 2025
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2026
€ 155,092
▼ 17% vs 2025
€ 24,248 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 52,696
▲ 198% vs 2025
Supplier invoices still open on the last day of the fiscal year.
€ 1,024
▼ 43% vs 2025
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Gross margin | € 30,507 | € 41,515 | € 23,676 | € 43,763 | ▲ 85% |
| Profit after taxes | € -8,654 | € 5,404 | € -26,239 | € -1,792 | ▲ € 24,447 |
| Equity | € 212,086 | € 217,490 | € 191,250 | € 189,458 | ▼ 1% |
| Total debts | € 202,001 | € 214,053 | € 208,282 | € 208,812 | |
| Cash | € 2,726 | € 13,333 | € 0 | € 11,822 | |
| Retained profit | € 150,086 | € 155,490 | € 129,250 | € 127,458 | ▼ 1% |
| Bank debt | € 162,213 | € 173,799 | € 186,420 | € 155,092 | ▼ 17% |
| Balance sheet total | € 414,087 | € 431,543 | € 399,532 | € 398,271 | |
| Employees (FTE) | - | - | 0.6 | 0.3 | ▼ 0.3 |
Key figures of APOTHEEK JANSSEN, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
What happened to APOTHEEK JANSSEN?
What happened at APOTHEEK JANSSEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Janssen Investment stepped down as director. NBB
- Anke Janssen stepped down as director. NBB
- New annual accounts for financial year 2026: loss of € 1,792. Source: NBB ↗
- Janssen Investment became a director. NBB
- Anke Janssen became a director. NBB
- New establishment in Knokke-Heist. KBO
- Start of the company according to the CBE. KBO
In short
From € 8,654 loss in 2023 to € 1,792 loss in 2026.
Best year ever: 2024, with € 5,404 profit.
A new publication or filing at APOTHEEK JANSSEN? We notify you, reason included.
Follow APOTHEEK JANSSENDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of JANSSEN INVESTMENT comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
APOTHEEK JANSSENThe shares are held by JANSSEN INVESTMENT (99.9%).
Directors
According to the 2026 annual accounts
Director · represented by Ilse Janssen
since 2023 · until 2029
since 2020 · until 2029
Shareholders
99.9%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Graaf d'Ursellaan 19
8301 Knokke-Heist
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
UPCLOUD, FI
Website info
Features
Security
Network
Details
- Company number
- 0426.331.232
- VAT number
- BE 0426.331.232
- Registered office
- Graaf d'Ursellaan 19, 8301 Knokke-Heist
- Names & denominations
- APOTHEEK JANSSEN
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 9 May 1984
- Peppol
- Active · Active since 23 Feb 2026
- Contact
- apotheekjanssenheist.be
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers